Share on StockTwits

Select Medical Holdings (NYSE:SEM) Director Thomas Scully sold 3,106 shares of the company’s stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $14.01, for a total transaction of $43,515.06. Following the completion of the transaction, the director now directly owns 143,389 shares of the company’s stock, valued at approximately $2,008,880. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Select Medical Holdings (NYSE:SEM) traded up 0.58% during mid-day trading on Friday, hitting $13.97. The stock had a trading volume of 239,234 shares. Select Medical Holdings has a 52 week low of $7.91 and a 52 week high of $16.17. The stock has a 50-day moving average of $15.11 and a 200-day moving average of $13.71. The company has a market cap of $1.816 billion and a price-to-earnings ratio of 15.80.

Select Medical Holdings (NYSE:SEM) last released its earnings data on Thursday, August 7th. The company reported $0.27 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.27. The company had revenue of $772.80 million for the quarter, compared to the consensus estimate of $777.16 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis. On average, analysts predict that Select Medical Holdings will post $0.94 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, August 29th. Investors of record on Wednesday, August 20th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Monday, August 18th.

Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.